Homepage

Stories / Access to Healthcare

How digital tools are improving access to healthcare

Through interdisciplinary partnerships, digital technologies such as artificial intelligence ...

Stories / Access to Healthcare

Educating patients and students – a day in the life of a doctor in South Africa (6 min read)

Get insights into the experiences of a healthcare professional in South Africa in this second episode ...

Stories / Access to Medicines

Biosimilars – Ten years of increasing access to state-of-the-art therapies (9 min read)

A tenth anniversary could be a fairly unremarkable date in healthcare, but 2016 marked the coming of ...

Our Mission and Purpose

We are a global leader in generic and biosimilar pharmaceuticals, committed to driving access to medicine

Explore Novartis

About Us

Who We Are

Our Work

What We Do

About Us

Corporate Responsibility

Careers

Job Search

Recent Updates

Featured / Aug 13

Renewed Sandoz partnership with World Child Cancer aims to double the impact for children in need over next five years

Learn More

View All

Renewed Sandoz partnership with World Child Cancer aims to double the impact for children in need over next five years

Media Release / Jul 27

Sandoz receives European Commission approval for biosimilar Hyrimoz® (adalimumab)

Media Release / Jul 18

Novartis delivers solid growth in second quarter and continues transformation to a focused medicines company

Media Release / Jun 15

Sandoz presents new long-term and switching data for biosimilars Zessly® (infliximab) and Erelzi® (etanercept) in rheumatoid arthritis

View All

#DYK? The EMA leads the way with the longest list of approved #biosimilars, versus other highly-regulated markets.… https://t.co/vjngM16zV7 4 days 4 hours ago

Our Work

At Sandoz, we discover new ways to improve and extend people’s lives. We pioneer novel approaches to help people around the world access high-quality medicine.

Learn More